GeneDx Holdings Corp. (WGS)

GeneDx Holdings Corp. (WGS) is a Diagnostics & Research company in the Healthcare sector listed on the NASDAQ.

As of Oct 23, 2026: market cap $2B; returns 1 day -16.4%, 1 week -11.7%, 1 year -55.1%.

GeneDx Holdings Corp. is a leader in genomic diagnostics, specializing in the delivery of whole exome sequencing (WES) and whole genome sequencing (WGS) to identify rare diseases. The company's business model is centered on its 'GeneDx Infinity' platform, which integrates one of the world's largest clinical rare disease datasets with AI-driven interpretation tools.

Groups WGS belongs to

• Healthcare
• Rare Diseases
• Biotechnology
• Life Sciences
• Health Diagnostics and Imaging
• Artificial Intelligence
• Precision Medicine
• Healthcare Technology
• AI in Healthcare
• Big Data
• Neonatal Care

WGS financial model: income statement, cash flow and balance sheet